Breaking News Instant updates and real-time market news.

AAOI

Applied Optoelectronics

$7.45 /

-0.23 (-2.99%)

16:30
03/25/20
03/25
16:30
03/25/20
16:30

Applied Optoelectronics price target lowered to $7.50 from $10 at Piper Sandler

Piper Sandler analyst Troy Jensen lowered the firm's price target on Applied Optoelectronics to $7.50 from $10 and keeps a Neutral rating on the shares. The analyst warns that the company's balance sheet issues could perpetuate additional problems, adding that its existing stock distribution plan is "extremely dilutive" for shareholders. Jensen adds that consensus estimates on Applied Optoelectronics may be too aggressive given the potential for supply chain issues and weakened demand.

AAOI Applied Optoelectronics
$7.45 /

-0.23 (-2.99%)

11/05/19 Rosenblatt
Applied Optoelectronics upgraded to Buy ahead of guidance at Rosenblatt
11/05/19 Rosenblatt
Applied Optoelectronics upgraded to Buy from Neutral at Rosenblatt
10/22/19 JPMorgan
Applied Optoelectronics downgraded to Underweight on valuation at JPMorgan
10/22/19 JPMorgan
Applied Optoelectronics downgraded to Underweight from Neutral at JPMorgan

TODAY'S FREE FLY STORIES

Upgrade
Altria Group upgraded to Buy from Hold at Panmure Gordon » 05:45
04/03/20
04/03
05:45
04/03/20
05:45
MO

Altria Group

$36.27 /

-1.43 (-3.79%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Philip Morris upgraded to Buy from Hold at Panmure Gordon » 05:44
04/03/20
04/03
05:44
04/03/20
05:44
PM

Philip Morris

$74.30 /

+3.02 (+4.24%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
President Trump 'hit 3M hard' over mask production » 05:43
04/03/20
04/03
05:43
04/03/20
05:43
MMM

3M

$137.86 /

+4.59 (+3.44%)

President Trump tweeted…

President Trump tweeted last night, "We hit 3M hard today after seeing what they were doing with their Masks. 'P Act' all the way. Big surprise to many in government as to what they were doing - will have a big price to pay!" Shares of 3M are down 3%, or $3.91, to $134.00 in pre-market trading.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Babcock upgraded to Neutral from Underperform at Exane BNP Paribas » 05:40
04/03/20
04/03
05:40
04/03/20
05:40
BCKIF

Babcock

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Experian downgraded to Neutral from Outperform at Exane BNP Paribas » 05:40
04/03/20
04/03
05:40
04/03/20
05:40
EXPGY

Experian

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Ashmore Group downgraded to Underperform from Neutral at Exane BNP Paribas » 05:39
04/03/20
04/03
05:39
04/03/20
05:39
AJMPF

Ashmore Group

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Next plc downgraded to Hold from Buy at Societe Generale » 05:37
04/03/20
04/03
05:37
04/03/20
05:37
NXGPY

Next plc

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Hexagon AB upgraded to Buy from Neutral at UBS » 05:37
04/03/20
04/03
05:37
04/03/20
05:37
HXGBY

Hexagon AB

$0.00 /

+ (+0.00%)

UBS upgraded Hexagon AB…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Schibsted upgraded to Buy from Hold at Kepler Cheuvreux » 05:36
04/03/20
04/03
05:36
04/03/20
05:36
SBBTF

Schibsted

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Adevinta upgraded to Hold from Reduce at Kepler Cheuvreux » 05:35
04/03/20
04/03
05:35
04/03/20
05:35
ADEVF

Adevinta

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Brunello Cucinelli downgraded to Reduce from Hold at Kepler Cheuvreux » 05:34
04/03/20
04/03
05:34
04/03/20
05:34
BCUCY

Brunello Cucinelli

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Yara upgraded to Buy from Hold at Kepler Cheuvreux » 05:34
04/03/20
04/03
05:34
04/03/20
05:34
YARIY

Yara

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Telenet upgraded to Buy from Hold at Kepler Cheuvreux » 05:33
04/03/20
04/03
05:33
04/03/20
05:33
TLGHF

Telenet

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Lanxess upgraded to Hold from Reduce at Kepler Cheuvreux » 05:32
04/03/20
04/03
05:32
04/03/20
05:32
LNXSF

Lanxess

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Evonik upgraded to Hold from Reduce at Kepler Cheuvreux » 05:32
04/03/20
04/03
05:32
04/03/20
05:32
EVKIF

Evonik

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Eldorado Resorts shares offer 250% upside from current levels, says Stifel » 05:31
04/03/20
04/03
05:31
04/03/20
05:31
ERI

Eldorado Resorts

$10.68 /

-1.015 (-8.68%)

, CZR

Caesars

$6.46 /

-0.17 (-2.56%)

Stifel analyst Steven…

Stifel analyst Steven Wieczynski lowered the firm's price target on Eldorado Resorts (ERI) to $35 from $80 and keeps a Buy rating on the shares. The stock closed yesterday down $1.02 to $10.67, and the analyst now sees over 250% upside from current levels. Eldorado is the "ultimate risk/reward stock" and the "possible rewards far outweigh the risks" that have now been overly priced into shares during the past six weeks, Wieczynski tells investors in a research note. The analyst "absolutely" believes the deal to acquire Caesars Entertainment (CZR) will close. Wieczynski says that while the shares of both Eldorado and Caesars show the market doesn't believe this deal will close, he sees it the other way.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Acadia one of the safer names to own right now, says Piper Sandler » 05:26
04/03/20
04/03
05:26
04/03/20
05:26
ACAD

Acadia

$41.66 /

+2.43 (+6.19%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Liberty Oilfield Services suspends dividend, announces strategic actions » 05:23
04/03/20
04/03
05:23
04/03/20
05:23
LBRT

Liberty Oilfield Services

$2.47 /

+0.195 (+8.59%)

Liberty Oilfield Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Jefferies cautious going into Atlassian fiscal Q3 results » 05:16
04/03/20
04/03
05:16
04/03/20
05:16
TEAM

Atlassian

$128.89 /

-4.84 (-3.62%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Verint price target lowered to $54 from $69 at Imperial Capital » 05:13
04/03/20
04/03
05:13
04/03/20
05:13
VRNT

Verint

$38.28 /

+1.77 (+4.85%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Lamar Advertising price target lowered to $71 from $93 at Imperial Capital » 05:13
04/03/20
04/03
05:13
04/03/20
05:13
LAMR

Lamar Advertising

$39.60 /

-5.27 (-11.75%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Dave & Buster's downgraded to Market Perform from Outperform at BMO Capital » 05:11
04/03/20
04/03
05:11
04/03/20
05:11
PLAY

Dave & Buster's

$10.04 /

-0.65 (-6.08%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Carlsberg upgraded to Neutral from Sell at Goldman Sachs » 05:09
04/03/20
04/03
05:09
04/03/20
05:09
CABGY

Carlsberg

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Immunomedics downgraded to Sell from Buy at Goldman Sachs » 05:07
04/03/20
04/03
05:07
04/03/20
05:07
IMMU

Immunomedics

$10.64 /

+0.52 (+5.14%)

Goldman Sachs analyst…

Goldman Sachs analyst Paul Choi double downgraded Immunomedics to Sell from Buy with a price target of $5, down from $24. The stock closed Thursday up 51c to $10.65. A Form 483 was published detailing ten observations of quality control, procedural, maintenance and other issues observed during the FDA's most recent inspection of the company's Morris Plains, NJ facility, Choi tells investors in a research note. Based on this, the analyst now thinks it is unlikely that Immunomedics' sacituzumab govitecan will be approved at its June 2, 2020 FDA action date for triple negative breast cancer. Choi finds it unclear whether Immunomedics will be able to address these concerns adequately, and is cautious on the company's ability to execute on the other ongoing clinical studies without the revenue generated in triple negative breast cancer.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Twitter upgraded to Buy from Neutral at Goldman Sachs » 05:04
04/03/20
04/03
05:04
04/03/20
05:04
TWTR

Twitter

$23.01 /

-0.33 (-1.41%)

Goldman Sachs analyst…

Goldman Sachs analyst Heath Terry upgraded Twitter to Buy from Neutral with a price target of $35, down from $39. The shares closed Thursday down 33c to $23.02. The 40% share selloff from the highs on February 17 has created an attractive entry point for investors, Terry tells investors in a research note. The acceleration in Twitter users implied by company guidance and third-party data, along with the pre-crisis acceleration in user growth and engagement driven by product investments, leave Twitter well positioned to exit this crisis "stronger than it entered it," contends the analyst. Terry believes new and returning users see the value of the platform, creating future inventory that Twitter will be able to better monetize as the company invests in its ad technology through the COVID-19 crisis.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.